SHERMAN MICHAEL A. (President and CEO) sold 7.5% of their position (28.15K shares) of ENDOCYTE INC on the open market
Open‑market sale worth $437.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/9/2018ACC: 0001179110-18-012089
DirectorOfficer· President and CEO
Since Oct 2018
-28.15K
Net shares
Net seller
$437.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
28.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−28.15K
Price / share
$15.55
Trade value
$437.75K
% of position
7.5%
10/5/2018
376.06K→347.92K
Total
Net shares
−28.15K
Net value
-$437.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/5/2018 | S · Sale | −28.15K | $15.55 | $437.75K | 7.5% | 376.06K | 347.92K |
| Total | −28.15K | -$437.75K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned19.92K
Total
19.92K indirect19.92K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 19.92K | Indirect |
| Total | 19.92K | 19.92K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported